Answers are grounded in this paper and cite their sources.
Systematic review highlights tranexamic acid's role in reducing intraoperative hemorrhage in DCR procedures, suggesting improved surgical outcomes.
Purpose Tranexamic acid (TXA) is an antifibrinolytic agent effective in reducing extensive blood loss and mortality. However, it lacks significant clinical evidence in peri-ocular procedures, including dacryocystorhinostomy (DCR). This study aims to assess the effectiveness of TXA in reducing intraoperative hemorrhage and improving surgical outcomes.
No takes yet. Share an insight, caveat, or question.
Azeem et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: